 Home > Medical News > Medical Science News > Scientists have developed a new type of bacterial therapy to improve the condition of 2/3 patients with eczema

Scientists have developed a new type of bacterial therapy to improve the condition of 2/3 patients with eczema

 Last Update: 2021-07-21
 Source: Internet
 Author: User

Tags

pathophysiology extrapyramidal symptoms

chondroitin side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

This new treatment method that uses symbiotic microorganisms to protect the skin is safe within 7 days

I believe that many people have suffered from dermatitis, especially atopic dermatitis (AD)

The pathophysiology of atopic dermatitis involves many factors, including host genetics, changes in skin barrier function, and immune abnormalities

On February 22, 2021, the Richard L.

First, the research team conducted selection and preclinical testing of symbiotic bacteria that are beneficial to human skin

Subsequently, the researchers evaluated the safety of ShA9 on the skin of participants with AD, and designed a randomized, double-blind phase 1 human clinical trial to better understand the mechanism of action and explore the effects of ShA9 on humans.

The included population was adults with moderate to severe AD on the ventral arm (n = 54), and patients with positive Staphylococcus aureus cultures.

The results of the trial showed that participants who received ShA9 had fewer AD-related adverse events.

In short, the researchers proposed that the best treatment for AD is to restore the epidermal barrier defect while suppressing the cause of inflammation

Reference materials:

https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Nature Sub-Journal: Scientists have developed a new type of bacterial therapy to improve the condition of 2/3 patients with eczema

03-23

Related Products

9,9-Dimethy-5-phenyl9H-fluoren-2-amine/2758134-82-4_Ouber

CAS No.: 2758134-82-4

Chemical Grade

$0.1/KG FOB

2-bromo-4'-(1,1-dimethylethyl)-1,1'-Biphenyl/1033692-34-0_Ouber

CAS No.: 1033692-34-0

Chemical Grade

$0.1/KG FOB

4-bromo-2-chloro-9-phenyl-9H-carbazole/2440193-72-4_Ouber

CAS No.: 2440193-72-4

Chemical Grade

$0.1/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Scientists have developed a new type of bacterial therapy to improve the condition of 2/3 patients with eczema

Related Articles

Nature Sub-Journal: Scientists have developed a new type of bacterial therapy to improve the condition of 2/3 patients with eczema